Cargando…
Multicentre prospective study to evaluate effectiveness and safety of gel-forming and hyaluronic-acid containing chewable tablets as add-on treatment in patients with gastroesophageal reflux disease (GERD) symptoms and unsatisfying proton pump inhibitor therapy
BACKGROUND: Gastroesophageal reflux disease (GERD) is a common disease which in the majority of patients is treated with proton pump inhibitors (PPI). However, up to 45% of the patients remain symptomatic on a standard dose of PPI. This study investigated the effectiveness and safety of an add-on th...
Autores principales: | Gross, Manfred, Neuschwander, Dennis, Steffens, Lisa, Thomsen, Jörn, Röschmann-Doose, Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483795/ https://www.ncbi.nlm.nih.gov/pubmed/37674104 http://dx.doi.org/10.1186/s12876-023-02946-6 |
Ejemplares similares
-
Buccal Buspirone as add–on Therapy to Omeprazole Versus Omeprazole in Treatment of Gastroesophageal Reflux Diseases (GERD)
por: Abdi, Saeed, et al.
Publicado: (2020) -
Functional Food in Relation to Gastroesophageal Reflux Disease (GERD)
por: Herdiana, Yedi
Publicado: (2023) -
A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD)
por: Kalaitzakis, Evangelos, et al.
Publicado: (2007) -
Co-occurrence of childhood functional constipation and gastroesophageal reflux disease (GERD)()
por: Ahmadipour, Shokoufeh, et al.
Publicado: (2022) -
Gastroesophageal Reflux Disease (GERD): Highlighting Diagnosis, Treatment, and Lifestyle Changes
por: Chhabra, Pratyaksh, et al.
Publicado: (2022)